New drugs for diabetes.
Tack
C J
CJ
Smits
P
P
D002219:Carbamates / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use; D002839:Chromans / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use; D003510:Cyclohexanes / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use*; D007333:Insulin Resistance; D008687:Metformin / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use; D000077715:Nateglinide; D010649:Phenylalanine / Q000031:analogs & derivatives / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use; D010880:Piperidines / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use; D013844:Thiazoles / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use; D045162:Thiazolidinediones; D000077288:Troglitazone
D002219:Carbamates; D002839:Chromans; D003510:Cyclohexanes; D007004:Hypoglycemic Agents; D010880:Piperidines; D013844:Thiazoles; D045162:Thiazolidinediones; D000077715:Nateglinide; D010649:Phenylalanine; C072379:repaglinide; D008687:Metformin; D000077288:Troglitazone